Repurposing the anti-malarial drug, quinacrine: new anti-colitis properties

BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory bowel disease that is associated with an increased risk of colorectal cancer in 8-10 years after disease onset. Current colitis treatment strategies do not offer a cure for the disease, but only treat the symptoms with limited success and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chumanevich, Alexander A., Witalison, Erin E., Chaparala, Anusha, Chumanevich, Anastasiya, Nagarkatti, Prakash, Nagarkatti, Mitzi, Hofseth, Lorne J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288159/
https://www.ncbi.nlm.nih.gov/pubmed/27447967
http://dx.doi.org/10.18632/oncotarget.10608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288159/
https://www.ncbi.nlm.nih.gov/pubmed/27447967
http://dx.doi.org/10.18632/oncotarget.10608

Ejemplares similares